Orthotopic heart transplantation is the gold standard treatment for end-stage heart failure.
However, the persistent shortage of available donor organs has resulted in an ever …

Heart transplantation remains plagued by a limitation in the number of donor organs that has
restricted its epidemiological benefit. Over the past decade, the number of heart transplants …

Introduction Heart transplantation is the treatment of choice for end-stage heart failure. There
is a mismatch between the number of donor hearts available and the number of patients …

The scarcity of donor hearts continues to be a challenge in transplants for advanced heart
failure patients. With an increasing number of patients on the waiting list for a heart …

Heart transplant remains the criterion standard treatment for patients in end-stage heart
failure. Improvement in the post-heart transplant outcomes in the last decade has …

Background Donor organ demand continues to outpace supply in heart transplantation.
Utilization of donation after circulatory death (DCD) hearts could significantly increase heart …

The recently concluded prospective Portable Organ Care System (OCS) Heart trial to
Evaluate the Safety and Effectiveness of The Portable Organ Care System Heart for …

Purpose The OCS Heart EXPAND Trial is a prospective, multi-center trial to evaluate the
effectiveness of the OCS™ to resuscitate, preserve and assess donor hearts that may not …

Objectives Heart donation after circulatory death was recently reintroduced in the United
States with hopes of increasing donor heart availability. We examined its national use and …

OBJECTIVES Demand for heart transplant donors worldwide continues to outstrip supply.
Transplanting hearts following donation after circulatory-determined death (DCD) is …